Head Congestion plus Mucus PE
NDC 42507-173, ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, tablet, coated, from HYVEE INC.
- Product NDC
- 42507-173
- Status
- Listed
- Labeler
- HYVEE INC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42507-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN325 mg/1
- GUAIFENESIN200 mg/1
- PHENYLEPHRINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42507-173-02 | 42507017302 | 2 BLISTER PACK in 1 CARTON (42507-173-02) / 12 TABLET, COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 42507-173 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42507-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42507-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.